Global Alliance for Genomics and Health
Peter Goodhand is a respected leader in the global health sector as a senior executive and board member in both the philanthropic and health research advancement communities. Goodhand played a key role in the creation of a global alliance to accelerate progress in genomic research and medicine. In June 2013, he was appointed acting Executive Director of the alliance for its critical development phase.
Prior to this role, he was the President and CEO of the Canadian Cancer Society - with a strong commitment to the Society’s Research Institute (formerly the National Cancer Institute of Canada) and the strategic development of cancer research in Canada. He was instrumental in the creation of the Occupational Cancer Research Centre (OCRC) and of the Canadian Centre for Applied Research in Cancer Control (ARCC).
Before joining the Society, Goodhand had a 20 year career in the global medical technology industry, including strategic marketing roles with multinational healthcare companies such as American Cyanamid and Johnson and Johnson. He served as board Chair and President of Canada’s Medical Device Industry association (MEDEC), chaired the Government of Canada’s Expert Working Group on the future of medical isotope production, and was a member of the Canadian delegation to the UN summit on non-communicable diseases. He is currently Chair of the Board, Health Technology Exchange (Ontario, Canada), Senior Advisor for Research and Policy, Health Charities Coalition of Canada, Board Member, MaRS EXCITE (Excellence in Clinical Innovation and Technology Evaluation), and a National Steering Committee member for CIHR’s SPOR initiative.
Goodhand had a 12-year experience as a patient advocate, caregiver and navigator throughout his family’s battle with a rare cancer.
- Acting Executive Director – The Global Alliance to Enable the Responsible Sharing of Genomic and Clinical Data
- Executive Lead for International Partnerships, Ontario Institute for Cancer Research